Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to The Lancet journal
Russia's health officials have given a go-ahead to testing a combination of the AstraZeneca coronavirus shot and the single-dose version of the domestically developed Sputnik V vaccine
The delta variant has some characteristics that give it a better chance of causing an infection, which means it escapes initial shield provided by antibodies, but vaccinated people are at a lower risk
The diabetes segment has been growing faster than the country's overall drug market
WHO warns of 'chaos' if individuals mix shots, Astra-Oxford said to be looking at tweaking vaccine to prevent rare clots, and other pandemic-related news across the globe
RDIF, Russia's sovereign wealth fund, and SII have also announced cooperation to produce the Russian Sputnik vaccine against coronavirus in India.
Canada announced its decision to donate 17.7 million doses of the AstraZeneca coronavirus vaccine to low- and middle-income countries
Countries are hoping a booster could bolster protection ahead of the return of colder weather that's optimal for the coronavirus's spread.
Expect 200-million AstraZeneca vaccine doses next year
Of those dead in Seychelles, five had taken Covishield and one had been given Sinopharm.
Biopharmaceutical company AstraZeneca India (AstraZeneca Pharma India Limited) on Wednesday announced that it has signed a memorandum of understanding with Bengaluru-based health startup, Docon Technologies, for digitising 1,000 clinics across India. Under the partnership, Docon will equip the identified clinics with customised Electronic Medical Record (EMR) systems enabling clinicians to access complete patient history, a joint statement said. "This willgo a long way in helping the clinical community better treat chronic patients and manage long-term complications of non-communicable diseases (NCDs) like diabetes and cardiovascular diseases', it said. Towards reaching the 1,000 clinics goal in 2021, on ground identification and support has been placed in 30 cities. Till now, as a part of the pilot phase, around 200 clinics have been upgraded with many of them being in Tier 1 & 2 towns, the statement said. In addition to providing the clinicians with a three day ..
SII Chief Executive Officer Adar Poonawalla said on Monday he had taken it up at the "highest levels".
The African countries have received the Covishield jab from WHO-led Covax
This study, published on the Lancet pre-print server, means all possible vaccination schedules involving the Oxford-AstraZeneca and Pfizer-BioNTech vaccines could potentially be used against Covid-19
Booster given six months after the 2nd dose beneficial, shows Oxford research
Reports suggest India plans to take this matter of non-inclusion of Covishield in the list of approved vaccines for European Union (EU) 'Green Pass' up with the EU
AstraZeneca vaccine immune response higher with longer gap, More than 50% kids in Mumbai have Covid-19 antibodies, according to a sero survey, and other top news of the day
Leaving a gap of as long as 10 months between the first and second doses increased level of protective antibodies, says Oxford University research.
British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford rolled out human trials for booster shots against Beta Covid variant
A single dose of Pfizer or AstraZeneca Covid-19 vaccine offers around 60 per cent protection against infection